
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings is a digital healthcare company in the medical device industry that has the potential for strong revenue growth and increasing profitability due to their innovative Zio monitoring system. The company has consistently beaten revenue estimates and raised guidance, highlighting the success of their core business and expanding into new market segments. Additionally, potential drivers such as international expansion, launch of new products, and operating leverage could provide further upside potential for the company. While there are potential risks such as competition and changes in reimbursement, the company's strong financial performance and strategic partnerships make them a favorable investment opportunity.
Bears say
iRhythm Holdings is facing potential challenges with growth in the future, as evidenced by only modest market share gains despite significant investments in research and development. Additionally, the company's impressive gross margin beat will not be sustainable in the long term, and further improvements in profitability may be slowed due to increased competition and regulatory issues with reimbursement. These factors could result in a bear case scenario with growth slowing to the low teens, making the stock overvalued at an EV/sales multiple of 5.5x our 2026 estimate.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares